HopeStage
Back to all studies
RecruitingNCT06751784

Fampridine and working memory in mild to moderate depression

About this titleRead the official source — NCT06751784
Medication studyAges 18–55Switzerland
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

What will I do during this study?

In this crossover study, you receive fampridine and placebo (an inactive comparison treatment) during separate 7.5-day periods, with tablets taken twice daily. The periods are separated by a washout interval of at least 6.5 days, which may extend to 28 days depending on scheduling.

Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 22, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
38
Sponsor
University of Basel
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Switzerland
Age range
From 18 Years to 55 Years
Official registry ID
NCT06751784
Official title
Show the full official title

Randomized Placebo-controlled Phase II Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression

Recruitment & locations

Currently recruiting

Basel

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Basel, a university.

Does this study involve medication?

Yes. The study involves medication, including Fampridine SR.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies